학술논문
Multi-institutional phase 2 study of TLK286 (TELCYTA (TM), a glutathione S-transferase P1-1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or resistant ovarian cancer
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
1048891X